Wednesday, 3 August 2022, the Faculty of Public Health, Universitas Indonesia (FPH UI) as the organizer of The 2nd ITTP-COVID 19, held the ITTP-COVID19 Series 2 Webinar. The webinar which is one of the seven Pre Conference activities in the context of the 2nd ITTP COVID 19 is open to the public. Supporting the implementation of the COVID-19 recovery plan in the Southeast Asia region, the webinar carries the theme “Health Economics Evaluation for Innovative Medicines”. The webinar takes place online via the Zoom Meeting platform and is widely broadcast via the FKM UI YouTube channel.
“During the 2 years of the COVID-19 pandemic, many lessons have been taught how vulnerable resilience in the health sector is, especially the combination of medical technology and medicine to deal with this pandemic. Through this experience, later there will be improvisations that will be utilized by health workers with the right target and adjust to cost efficiency,” said Chair of the Conference of the 2nd ITTP, dr. Agustin Kusumayati, M.Sc., Ph.D., in his speech.
The webinar presents Prof. dr. Asri C. Adisasmita, M.P.H., M.Phil., Ph.D., who discussed the clinical outcome – systematic review. Prof. Asri explained the key issues for framing the review questions and designing the review, including the prognostic predictive model, the intended scope of the review, the type of predictive modeling study, the target population to which the model was intended, the results, and the prediction timeframe, as well as the moment of use of the model wanted.
Dr. dr. Rizaldi T. Pinzon, Sp.S., M.Kes., from the Department of Neurology at Bethesda Hospital comprehensively explained the real word of clinical evidence. “Real world evidence is data regarding the use or potential benefits and risks of drug derivative sources other than traditional clinical trials. Recommendations for improving the process of collecting real word data (RWD) in Indonesia include standardizing variables between different sources, assessing the costs and benefits of data collection, and increasing the credibility and validity of relevant study designs,” explained dr. Rizaldi.
Furthermore, Professor of FPH UI, Prof. Dr. drg. Mardiati Nadjib, M.S., explained about economic evaluation. “Basically a budget impact analysis, it compares current conditions and current proven conditions and there are factors, namely population size, number of patients, target population, utilization of resources in the healthcare system that accompanies it. From the analysis, there will be visible cost efficiency in fulfilling health aspects,” said Prof. Dr. drg. Mardiati Nadjib, M.S.
Furthermore, Prof. Dr. dr. Sabarinah, M.Sc., Professor of FPH UI, and Ery Setiawan, S.K.M., ME, AAAK., from Charles Darwin University presented a comprehensive survival analysis for Health Technology Assessment (HTA) and budget impact analysis-Indonesia case.
“HTA will bridge technological progress with the integration of decision-making at various levels of the Indonesian health technology market,” added Prof. Budi Hidayat, S.KM, MPPM, Ph.D., in his presentation on from evidence to policy implications.
On the same occasion, Syed Salleh Abdul Rahman, Ph.D., as the Health Economics Expert Malaysia, was present to discuss budget impact analysis in terms of guidelines and case studies in Malaysia. Syed Salleh Abdul Rahman explained that despite advances in therapy in Malaysia, chronic obstructive pulmonary disease being an expensive disease, the results showed that a change in treatment approach proved clinically beneficial to improve quality of care with better treatment outcomes at the expense of increasing medical costs by RM19.5 million more than 5 years.
This webinar is the last series of a number of Pre Conferences that were held ahead of the peak of implementation of The 2nd ITTP COVID 19, 6 to 8 August 2022. All activities of The 2nd ITTP COVID 19 can be accessed through the website https://scifes.fkm.ui.ac.id /ittp. The series 2 webinar recording can also be watched at the following link https://www.youtube.com/watch?v=e1IR7DTOJcE. (AHS)